Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Alcoa (AA) Upgraded to Buy at Nomura Ahead of Tonight's Earnings Report
-
Bed Bath & Beyond (BBBY) Q3 Results In-Line, PT Raised to $76 at Nomura
-
Nomura Securities Upgrades XL Group plc (XL) to Buy
-
Nomura Securities Starts ULTA Salon (ULTA) at Neutral
-
Nomura Securities Starts Sally Beauty Holdings (SBH) at Neutral
-
Nomura Securities Starts Mead Johnson Nutrition (MJN) at Buy; Better U.S. Birth Rates, Consistency in China
-
Nomura Securities Upgrades Anheuser-Busch InBev (BUD) to Buy
-
Nomura Securities Downgrades Diageo plc (DEO) to Neutral
-
Nomura Securities Upgrades Molson Coors (TAP) to Buy; Lower Gas Prices Means More Beer Drinking
-
Nomura Discuses Implication for Google (GOOG) on Potential Loss as Apple (AAPL) Default Search Engine
-
Synageva BioPharma (GEVA) Prices Larger 3M Common Offering at $94.19/Share
-
Synageva (GEVA) PT Raised to $124 at Nomura
-
Receptos (RCPT) PT Raised to $173 at Nomura
-
Gilead Sciences (GILD) PT Trimmed to $146 at Nomura; 'Buy' Maintained
-
Amgen (AMGN) PT Raised to $200 at Nomura
-
Neurocrine Bio. (NBIX) Named Top 2015 Small-Cap Biotech Pick at Nomura; PT Raised to $34
-
BioMarin (BMRN) Named Top 2015 Mid-Cap Biotech Pick at Nomura
-
Celgene (CELG) Named Top Large Cap Biotech Pick for 2015 at Nomura; PT Raised to $150
-
Pre-Open Stock Movers 1/5: (CNAT) (STXS) (URZ) (CEMP) Higher; (BCLI) (OAS) (SNY) Lower (more...)
-
Nomura Securities Downgrades Pharmacyclics (PCYC) to Neutral
-
Nomura Securities Downgrades Alexion Pharmaceuticals (ALXN) to Neutral
-
Nomura Securities Downgrades Biogen (BIIB) to Neutral
-
Form 6-K NOMURA HOLDINGS INC For: Jan 05
-
Top 10 News for 12/22 - 12/26: Dow Reaches New Record; GDP Outpaces in Q3; Ruble Rebounds on Reduced Reserves
-
Nomura Bullish on FireEye (FEYE) Given Its Managed Defense Solution to Cybersecurity
-
Japan Core Inflation Slows in November
-
China's Central Bank Acts Further to Ease Policy
-
Form 6-K NOMURA HOLDINGS INC For: Dec 24
-
Form 6-K NOMURA HOLDINGS INC For: Dec 24
-
THL Credit Announces Appointment of James Kern to its Board of Directors
-
Nomura Securities Starts Axalta Coating Systems (AXTA) at Buy
-
Form 6-K NOMURA HOLDINGS INC For: Dec 22
-
Streetinsider.com's Hot Lunchtime Reads 12/19: (SNE) (NQ) (HLT) (QCOM)
-
Nomura Names Three Top Picks for 2015 in Gaming & Lodging (MGM) (HLT) (NCLH)
-
Pier 1 Imports (PIR) Q3 Results Encouraging, Nomura Says
-
Nike (NKE) Q2 'Nothing Short of Amazing', Nomura Says; Outlook Slightly Tempered on Macro/FX
-
Form 6-K NOMURA HOLDINGS INC For: Dec 19
-
AK Steel (AKS) FCF Thesis Intact, Nomura Says
-
Nomura Securitie Maintains Bullish View on Steel Dynamics (STLD) Despite Weak Guidance
-
Lennox (LII) Building Blocks of Growth Remain the Same, Nomura Says
-
Oracle (ORCL) Bookings Inflecting Up in the Cloud, Nomura's Sherlund Says; PT to $49
-
Nomura Securities Starts Boston Beer Company (SAM) at Buy
-
All Eyes on Fed and 'Considerable Time'
-
Form 6-K NOMURA HOLDINGS INC For: Dec 17
-
Nomura Sees Opportunity to Accumulate Qihoo 360 (QIHU) Shares
-
Nomura Prefers Specialized Retailers Versus Big-Box in Home Improvement (TSCO) (LL) (HD) (LOW)
-
Notable Analyst Rating Changes 12/16: (PLXS) (CROX) (GRUB) Upgraded; (GM) (AXAS) (EOX) Downgraded
-
Nomura Remains on Sidelines with SanDisk (SNDK)
-
Micron (MU) PT Raised to $45 at Nomura Securities on DRAM Outlook
-
Nomura Comments on Russia Emergency Rate Hike

